How many institutions held APDN - Applied DNA Sciences, Inc. - Common Stock, $0.001 par value in Q2 2024?

16 institutional investors reported APDN - Applied DNA Sciences, Inc. - Common Stock, $0.001 par value for Q2 2024. Use the holders table for investor-level position and value details.

Applied DNA Sciences, Inc. - Common Stock, $0.001 par value (APDN)

Q: What does CUSIP 03815U409 represent in this 13F holders report?

CUSIP 03815U409 is the security identifier for APDN - Applied DNA Sciences, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 03815U409

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class: Equity / Common Stock, $0.001 par value
Total 13F shares: 866,116
Total 13F value: $353,951
Share change: +866,116
SEC-reported price per share: $0.41
Number of holders: 16
Value change: +$353,951
Number of buys: 16
Shares outstanding: 1,384,245

Security key

03815U409

Report period

Q2 2024

Institutions

Top holders

APDN full security history Ownership snapshot Full 13F holder table BNB PLUS CORP. SEC filings BNB PLUS CORP. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of APDN - Applied DNA Sciences, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

15/15

Latest evidence

31 Mar 2024

13F Lead comparable stake: 17% Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 17%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Comparable ownership Top 5

ARMISTICE CAPITAL, LLC 17%

AMH Equity Ltd 7%

VANGUARD GROUP INC 2.3%

GEODE CAPITAL MANAGEMENT, LLC 1.8%

BlackRock Finance, Inc. 1.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	13F Company 13F	17%	$531,358 1,295,995 shares	—	31 Mar 2024
AMH Equity Ltd	13F Company 13F	7%	$221,558 540,385 shares	—	31 Mar 2024
VANGUARD GROUP INC	13F Company 13F	2.3%	$72,148 175,970 shares	—	31 Mar 2024
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	1.8%	$57,086 139,187 shares	—	31 Mar 2024
BlackRock Finance, Inc.	13F Company 13F	1.3%	$41,531 101,295 shares	—	31 Mar 2024
Silverberg Bernstein Capital Management LLC	13F Company 13F	1.3%	$40,303 98,301 shares	—	31 Mar 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

866,116

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Q2 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q2 2024 value	Value change	Value Chg %